SCHEMBL5843370

SCHEMBL5843370

Nc1ccc(-c2ccc(F)c(F)c2)cc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.71
ALOX15 P16050 2/20 0.71
CYP3A4 P08684 1/20 0.71
HSD17B1 P14061 5/20 0.44
HSD17B2 P37059 5/20 0.44
KDM1A O60341 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 3/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
BRD4 O60885 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
APP P05067 1/20 0.41
ESR2 Q92731 2/20 0.40
ESR1 P03372 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29861102 0.89 HSD17B10 (0.74) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2
SCHEMBL29549758 0.84 CYP3A4 (1.00) HSD17B10ALOX15CYP3A4MEN1KMT2A
SCHEMBL29365557 0.84 CYP3A4 (1.00) HSD17B10ALOX15CYP3A4MEN1KMT2A
SCHEMBL23924225 0.84 CYP3A4 (1.00) HSD17B10ALOX15CYP3A4MEN1KMT2A
SCHEMBL105866 0.84 CYP3A4 (1.00) HSD17B10ALOX15CYP3A4MEN1KMT2A
SCHEMBL21857737 0.83 HSD17B10 (0.59) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2
SCHEMBL5843970 0.82 CYP3A4 (0.63) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2
SCHEMBL5845248 0.82 CYP3A4 (0.63) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2
SCHEMBL5843755 0.82 CYP3A4 (0.63) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2
SCHEMBL5844850 0.82 CYP3A4 (0.63) HSD17B10ALOX15CYP3A4HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US claimed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP claimed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US claimed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO claimed
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US disclosed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP disclosed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives KRT18, CBR3, CCNB3 HSD17B10 913/4885ALOX15 3006/4885CYP3A4 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.